Spectroscopic Changes Associated with Mild Cognitive Impairment and Dementia in Parkinson’s Disease

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Dementia and Geriatric Cognitive Disorders

• Publication date

  2012-12-03

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1159/000345537PMID 23208306
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism

  2011cited by this paper
• Longitudinal Changes in Cognition in Parkinson’s Disease with and without Dementia

  2011cited by this paper
• The function of the left anterior temporal pole: evidence from acute stroke and infarct volume

  2011cited by this paper
• Mild cognitive impairment in Parkinson disease

  2010cited by this paper
• Cognitive Characteristics Associated with Mild Cognitive Impairment in Parkinson’s Disease

  2009cited by this paper
• The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort.

  2009cited by this paper
• Brain N-acetylaspartate is Reduced in Parkinson Disease With Dementia

  2008cited by this paper
• N-Acetylaspartate and N-acetylaspartylglutamate

  2008cited by this paper
• The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years

  2008cited by this paper
• The progression of pathology in longitudinally followed patients with Parkinson’s disease

  2008cited by this paper
• A Volumetric Magnetic Resonance Imaging Study of Entorhinal Cortex Volume in Dementia with Lewy Bodies

  2008cited by this paper
• Parkinson's disease‐cognitive rating scale: A new cognitive scale specific for Parkinson's disease

  2008cited by this paper
• Determinants of disability and quality of life in mild to moderate Parkinson disease

  2008cited by this paper
• Clinical diagnostic criteria for dementia associated with Parkinson's disease

  2007cited by this paper
• Evolution of cognitive dysfunction in an incident Parkinson's disease cohort.

  2007cited by this paper
• MRI for the differential diagnosis of neurodegenerative parkinsonism in clinical practice.

  2007cited by this paper
• Subtypes of mild cognitive impairment in parkinson's disease: Progression to dementia

  2006cited by this paper
• Cognitive Change in Parkinson Disease

  2006cited by this paper
• Diagnosis and management of dementia with Lewy bodies

  2005cited by this paper
• Cerebral atrophy and its relation to cognitive impairment in Parkinson disease

  2005cited by this paper
• Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium

  2005cited by this paper
• Cognitive profile of patients with newly diagnosed Parkinson disease

  2005cited by this paper
• Functional Imaging in Parkinson’s Disease and Dementia with Lewy Bodies

  2004cited by this paper
• Switching from ergot to nonergot dopamine agonists in Parkinson's disease: A clinical series and five‐drug dose conversion table

  2004cited by this paper
• Posterior cingulate metabolic changes occur in Parkinson's disease patients without dementia.

  2004cited by this paper
• Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study.

  2003cited by this paper
• Dementia in Parkinson disease: a proton magnetic resonance spectroscopy study.

  2002cited by this paper
• Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDG-PET study.

  2000cited by this paper
• Recognition memory impairment in Parkinson's disease: power and meta-analyses.

  2000cited by this paper
• What contributes to quality of life in patients with Parkinson's disease?

  2000cited by this paper
• A Proton Magnetic Resonance Spectroscopy Study of the Striatum and Cerebral Cortex in Parkinson's Disease

  1999cited by this paper
• Lexical, semantic, and action verbal fluency in Parkinson's disease with and without dementia.

  1999cited by this paper
• Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration.

  1997cited by this paper
• N-acetylaspartylglutamate, N-acetylaspartate, and N-acetylated alpha-linked acidic dipeptidase in human brain and their alterations in Huntington and Alzheimer's diseases.

  1997cited by this paper
• Proton magnetic resonance spectroscopy of the striatum in Parkinson's disease patients with motor response fluctuations.

  1996cited by this paper
• The Mattis Dementia Rating Scale

  1994cited by this paper
• Estimation of metabolite concentrations from localized in vivo proton NMR spectra

  1993cited by this paper
• Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

  1992cited by this paper
• A New Clinical Scale for the Staging of Dementia

  1982cited by this paper

• Cerebellar Structural and N-Acetylaspartate, Choline, and Creatine Metabolic Profiles in Parkinson’s Disease and Essential Tremor

  2024cites this paper
• Radionuclide Imaging of the Neuroanatomical and Neurochemical Substrate of Cognitive Decline in Parkinson’s Disease

  2024cites this paper
• MRS in neurodegenerative dementias, prodromal syndromes and at‐risk states: A systematic review of the literature

  2023cites this paper
• Proton Magnetic Resonance Spectroscopy for Diagnosis of Non-Motor Symptoms in Parkinson's Disease

  2022cites this paper
• Magnetic Resonance Imaging Markers for Cognitive Impairment in Parkinson’s Disease: Current View

  2022cites this paper
• Predicting cognitive decline in Parkinson’s disease using FDG-PET–based supervised learning

  2022cites this paper
• Identification of metabolic correlates of mild cognitive impairment in Parkinson's disease using magnetic resonance spectroscopic imaging and machine learning

  2022influential citation
• Does Prefrontal Glutamate Index Cognitive Changes in Parkinson’s Disease?

  2022influential citation
• In vitro and in vivo NMR based metabolomics in Parkinson's disease

  2022cites this paper
• Frontal lobe metabolic alterations characterizing Parkinson’s disease cognitive impairment

  2020cites this paper
• A Dietary Ketone Ester Normalizes Abnormal Behavior in a Mouse Model of Alzheimer’s Disease

  2020influential citation
• Apathy as a behavioural marker of cognitive impairment in Parkinson’s disease: a longitudinal analysis

  2019cites this paper
• Can neuroimaging predict dementia in Parkinson’s disease?

  2018cites this paper
• Characterizing Cognitive Impairment in Parkinson's Disease

  2017cites this paper
• Magnetic Resonance Spectroscopy in Parkinsonian Disorders

  2016cites this paper
• Basic Principles and Clinical Applications of Magnetic Resonance Spectroscopy in Neuroradiology.

  2016cites this paper
• Biomarkers for dementia and mild cognitive impairment in Parkinson's disease

  2016cites this paper
• Proton MR Spectroscopy for Monitoring Pathologic Changes in the Substantia Nigra and Globus Pallidus in Parkinson Disease.

  2016cites this paper
• MR Spectroscopy in Neuroradiology

  2015cites this paper
• Brain metabolism assessed via proton magnetic resonance spectroscopy in patients with amnestic or vascular mild cognitive impairment.

  2015cites this paper
• Mild Cognitive Impairment and Parkinson’s Disease - Something to Remember

  2015cites this paper
• Early Biomarkers in 1H Nuclear Magnetic Resonance Spectroscopy of Striatal Pathological Mechanisms after Acute Carbon Monoxide Poisoning in Rats.

  2015cites this paper
• Magnetic Resonance Spectroscopy in the Diagnosis of Dementia with Lewy Bodies

  2014cites this paper
• Parkinson ' s disease and degenerative parkinsonism : relationship between clinical and neurobiological aspects

  2014cites this paper
• Validation of the Chinese Version of Addenbrooke's Cognitive Examination-Revised for Screening Mild Alzheimer's Disease and Mild Cognitive Impairment

  2013cites this paper
• Measuring functional impact of cognitive impairment: validation of the Parkinson's disease cognitive functional rating scale.

  2013cites this paper
• Comparison of activities of daily living impairments in Parkinson's disease patients as defined by the Pill Questionnaire and assessments by neurologists

  2013cites this paper
• Front & Back Matter

  2013cites this paper
• ROLE OF FUNCTIONAL ELECTRICAL STIMULATION AND OF TRANSCRANIAL MAGNETIC STIMULATION IN IMPROVING MOTOR PEFORMANCE IN PARKINSONʼS DISEASE

  2013cites this paper
• Predictors of Mild Cognitive Impairment in Early-Stage Parkinson's Disease

  2013cites this paper